Comparison of IPC Therapy as an Alternative or an Adjunct to MLD Within CDT for BCRL

Breast cancer is the most common cancer among women worldwide and lymphedema is one of its most significant complications. Breast cancer-related lymphedema (BCRL) may develop shortly after treatment or even years later, causing physical and psychological burden, functional impairment, and reduced quality of life. Complete decongestive therapy (CDT), which includes manual lymph drainage (MLD), compression, skin care, and exercise, is the standard approach. Intermittent pneumatic compression (IPC) has been proposed as an additional option, and current consensus reports emphasize the need for stu

Trial Details

NCT ID
NCT07154043
Phase
NA
Sponsor
Pamukkale University
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • Complete Decongestive Therapy (CDT)
  • CDT + Intermittent Pneumatic Compression (IPC)
  • CDT without Manual Lymph Drainage plus Intermittent Pneumatic Compression
Locations (sample)
  • Denizli, Turkey (Türkiye)|37.77417,29.0875

Key Eligibility Criteria

  • Female gender
  • Patients aged 18-65 years
  • Having a history of unilateral mastectomy and lymph node dissection at least one year ago due to breast cancer diagnosis.
  • Having unilateral breast cancer-related upper extremity lymphedema (\>20% volume difference between the two upper extremities or \>2 cm difference …

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →